| arznei-telegramm® 10/2015 |
THERAPY FROM A CRITICAL VIEWPOINT |
| EMPA-REG OUTCOME study with the SGLT-2 inhibitor empagliflozin (JARDIANCE) … the big question: a breakthrough? |
| Tranexamic acid for traumatic bleeding - transferability of the CRASH-2 data is disputed |
NEW ON THE MARKET |
| Tiotropium plus olodaterol (SPIOLTO RESPIMAT) against COPD |
a-t READER'S QUESTIONS AND COMMENTS |
| Flu vaccination: disadvantage for people with statutory health insurance? |
| Rules for collegial cooperation |
IN BRIEF | Warning regarding Q fever from live cell therapy |
CURRENT ADR NETWORK REPORT |
| Asthma-like attacks with OCTENIDOL mouthwash solution |
SIDE EFFECTS |
| Respiratory depression in children following use of tramadol |
| Progressive multifocal leukoencephalopathy with fumaric acid esters (FUMADERM, TECFIDERA) despite only moderate lymphopenia |
| Aortic aneurysm with fluoroquinolones |
e a-t IN THE INTERNET |
| OCTENIDOL for MRSA decontamination? |